Product Information
NITROFURANTOIN MONO-MCR 100 MG is a generic product labeled by Major Pharmaceuticals, priced at $0.3226 per EA under NDC 00904713761. Its NADAC has been published 145 times since Aug 23, 2023.
FDA first approved this application on Dec 24, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 75 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904713761
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
NITROFURANTOIN; NITROFURANTOIN MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA020064FDA Approved
12/24/1991
TE Code
AB
On Market Since
5/25/2011
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MONO-MCR 100 MG has been published 145 times since Aug 23, 2023, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3226 per EA |
|---|---|
| All-time high | $0.5568 (Jan 10, 2024) |
| All-time low | $0.2561 (Nov 20, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.3226 |
| Median price | $0.3492 |
| Average price | $0.3945 |
| Largest weekly change | +28.5% (Jun 19, 2024) |
| Weeks tracked | 145 |
| Tracking since | Aug 23, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.8%
1Y
-1.9%
3Y
-35.3%
5Y
N/A
All
-24.5%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitrofurantoin Monohydrate/Macrocrystalline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MONO-MCR 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MONO-MCR 100 MG, manufactured by Major Pharmaceuticals, is $0.3226 per EA (NDC 00904713761), effective May 27, 2026.
How has the price of NITROFURANTOIN MONO-MCR 100 MG changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has declined 24.5%. It has been tracked across 145 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MONO-MCR 100 MG?
Since Aug 23, 2023, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has ranged from a low of $0.2561 (Nov 20, 2024) to a high of $0.5568 (Jan 10, 2024), with a median of $0.3492 per EA.
Are there cheaper alternatives to NITROFURANTOIN MONO-MCR 100 MG?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROFURANTOIN MONO-MCR 100 MG, is $0.2958 per EA — about 8% below NITROFURANTOIN MONO-MCR 100 MG.
Who manufactures NITROFURANTOIN MONO-MCR 100 MG?
NITROFURANTOIN MONO-MCR 100 MG (NDC 00904713761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.